The National Health Insurance Administration (NHIA) said it plans to expand the coverage eligibility for receiving a third-generation targeted drug for lung cancer patients with the epidermal growth factor receptor (EGFR) starting next month.
The eligibility would be expanded to include people with stage 3b EGFR-mutated lung cancer, which is expected to benefit about 4,000 people, allowing them to save about NT$1.15 million (US$36,005) per year in medical expenses.
The expanded eligibility is expected to cost the NHI program between NT$4.1 billion and NT$5 billion per year, and with the annual expense of about NT$3.3 billion on eligible patients, the targeted drug would be the most expensive single type of drug in NHI history.
Photo: Chiu Chih-jou, Taipei Times
Lung adenocarcinoma is the most common type of lung cancer in Taiwan and KRAS mutations occur in about 20 to 40 percent of lung adenocarcinomas in Western populations, NHIA Director-General Shih Chung-liang (石崇良) said.
However, in Taiwan, KRAS mutations only occur in about 8 to 10 percent of patients with lung adenocarcinomas, while EGFR mutations occur in about 55 to 60 percent of patients with lung adenocarcinomas, he said.
The NHI program since April 2020 has conditionally covered a third-generation targeted drug called Tagrisso (osimertinib) for the treatment of EGFR-mutated lung cancer, but the eligibility was reduced in April 2022, which had caused an uproar among patients and medical professionals.
Studies published in international journals have suggested that compared with the first-generation targeted drug, the third-generation drug can reduce the risk of mortality by 20 percent.
With many calls for the NHI program to expand eligibility, Shih said the administration plans to expand the eligibility of Tagrisso from its current eligibility of stage 4 (metastasized) lung cancer to include stage 3b EGFR-mutated lung cancer with local invasiveness or metastases.
The Pharmaceutical Benefit and Reimbursement Scheme Joint Committee has approved the expanded eligibility, and it is scheduled to take effect on Oct. 1 at the earliest, he said.
About 3,400 people are treated with Tagrisso each year, which is an NHI expenditure of about NT$3.3 billion per year, NHIA statistics showed. After the eligibility expansion, it would increase the expenditure to more than NT$7 billion.
The total expenditure for NHI-covered medical treatment last year was more than NT$24.3 billion, the highest among all cancer types, and drug fees accounted for NT$12.2 billion, with a five-year average growth rate of 12.7 percent.
Regarding people with lung cancer without gene mutations that cannot receive the targeted drug, Shih said specialists have suggested including immunotherapy drugs for treating metastasized small cell lung cancer in NHI coverage, so there might be good news after the agency negotiates with drug companies.
An estimated 272 to 359 patients each year are expected to benefit from it, allowing them to save about NT$1.45 million per person per year, he added.
GREAT POWER COMPETITION: Beijing views its military cooperation with Russia as a means to push back against the joint power of the US and its allies, an expert said A recent Sino-Russian joint air patrol conducted over the waters off Alaska was designed to counter the US military in the Pacific and demonstrated improved interoperability between Beijing’s and Moscow’s forces, a national security expert said. National Defense University associate professor Chen Yu-chen (陳育正) made the comment in an article published on Wednesday on the Web site of the Journal of the Chinese Communist Studies Institute. China and Russia sent four strategic bombers to patrol the waters of the northern Pacific and Bering Strait near Alaska in late June, one month after the two nations sent a combined flotilla of four warships
THE TOUR: Pope Francis has gone on a 12-day visit to Indonesia, Papua New Guinea, East Timor and Singapore. He was also invited to Taiwan The government yesterday welcomed Pope Francis to the Asia-Pacific region and said it would continue extending an invitation for him to visit Taiwan. The Ministry of Foreign Affairs made the remarks as Pope Francis began a 12-day tour of the Asia-Pacific on Monday. He is to travel about 33,000km by air to visit Indonesia, Papua New Guinea, East Timor and Singapore, and would arrive back in Rome on Friday next week. It would be the longest and most challenging trip of Francis’ 11-year papacy. The 87-year-old has had health issues over the past few years and now uses a wheelchair. The ministry said
TAIWANESE INNOVATION: The ‘Seawool’ fabric generates about NT$200m a year, with the bulk of it sourced by clothing brands operating in Europe and the US Growing up on Taiwan’s west coast where mollusk farming is popular, Eddie Wang saw discarded oyster shells transformed from waste to function — a memory that inspired him to create a unique and environmentally friendly fabric called “Seawool.” Wang remembered that residents of his seaside hometown of Yunlin County used discarded oyster shells that littered the streets during the harvest as insulation for their homes. “They burned the shells and painted the residue on the walls. The houses then became warm in the winter and cool in the summer,” the 42-year-old said at his factory in Tainan. “So I was
‘LEADERS’: The report highlighted C.C. Wei’s management at TSMC, Lisa Su’s decisionmaking at AMD and the ‘rock star’ status of Nvidia’s Huang Time magazine on Thursday announced its list of the 100 most influential people in artificial intelligence (AI), which included Taiwan Semiconductor Manufacturing Co (TSMC) chairman and chief executive officer C.C. Wei (魏哲家), Nvidia CEO Jensen Huang (黃仁勳) and AMD chair and CEO Lisa Su (蘇姿丰). The list is divided into four categories: Leaders, Innovators, Shapers and Thinkers. Wei and Huang were named in the Leaders category. Other notable figures in the Leaders category included Google CEO Sundar Pichai, Microsoft CEO Satya Nadella, OpenAI CEO Sam Altman and Meta CEO and Facebook founder Mark Zuckerberg. Su was listed in the Innovators category. Time highlighted Wei’s